SpeedWeed

MARCH 21, 2021

With all the buzz surrounding Delta-8-tetrahydrocannabinol (THC) in the cannabis industry, many questions circulate around what the up-and-coming cannabinoid is, where it comes from, and its legal status. The cannabinoid Delta-8-THC is a natural component of cannabis, Russo says. “[W]ith Where It Comes From. That is totally wrong.”.

Research and Development 52

Research and Development Hydroponic DEA Cannabinoids 52

Cannabis Law Report

JULY 27, 2021

The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. The collaboration represents the Company’s first funded study with a research institution in the United States. organization to help advance scientific research into the potential medical benefits of cannabinoids.

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Medicinal Genomics

JULY 13, 2023

So here are just a dozen new developments, breakthroughs, and aha moments from this year’s summit that might just convince you to circle CannMed 24 on your calendar right now. the VP of Research & Development at Biopharmaceutical Research Company, Inc., But if you weren’t able to be there, you wouldn’t know that.

Research and Development 52

Research and Development Cannabinoids Medicine DEA 52

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

SpeedWeed

AUGUST 12, 2021

Our latest research empowers us with new insights to assess each grower’s objectives, weigh those objectives against a facility’s unique financial, environmental and energy parameters, and then ultimately derive a tailored solution for each cultivator.”. Merlice tomatoes.

DEA 52

DEA Research and Development Hemp Cultivation 52

Veriheal

DECEMBER 28, 2021

Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

CannaMD

AUGUST 8, 2020

In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. However, many of these products contain a number of other cannabinoids as well. To understand cannabinoids, we need to take a closer look at the endocannabinoid system. In 1970, the U.S.

CBD 99

CBD DEA Research and Development Hemp 99

Cannabis Law Report

JULY 6, 2021

The Congressional Research Service (CRS) released a report which says there are “three leading markets for hemp, each based on the part of the plant used: fiber, seed/grain, and flower.” The FDA has jurisdiction over the area and hasn’t developed rules allowing for CBD products in the food supply. Marijuana Moment.

Hemp 105

Hemp CBD DEA Legalization 105

FloridaMarijuana.net

JULY 8, 2018

The National Academies of Sciences reports that PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. The psychological symptoms that develop because of the trauma affect mood, cognition, memories (both suppression and the inability to form new memories) and physical health.

Strains 190

Strains Indica Hybrid Research and Development 190

Cannabis Law Report

AUGUST 18, 2022

The laboratory researched the fine print of every state’s rules for hemp sampling, THC potency, cannabinoid content, residual solvents, pesticides, mycotoxins, heavy metals, and microbiology. With that research, they created elaborate matrices to compare each mandate. Source: [link].

Compliance 52

Compliance Compliance Hemp Research and Development 52

Freedom Leaf

DECEMBER 4, 2018

For the first but not the last time, events on the global stage had an impact on his life, career and research. In 1917, Adams took a position with the National Research Council in Washington, DC and its associated Chemical Warfare Service. Roger Adams’ Cannabis Research Commences. Cannabis was administered to U.S.

CBD 112

CBD Research and Development THC Cannabinoids 112

SpeedWeed

MARCH 21, 2021

With all the buzz surrounding Delta-8-tetrahydrocannabinol (THC) in the cannabis industry, many questions circulate around what the up-and-coming cannabinoid is, where it comes from, and its legal status. The cannabinoid Delta-8-THC is a natural component of cannabis, Russo says. “[W]ith Where It Comes From. That is totally wrong.”.

THC 52

THC Business DEA Cannabinoids 52

SpeedWeed

MARCH 17, 2021

With all the buzz surrounding Delta-8-tetrahydrocannabinol (THC) in the cannabis industry, many questions circulate around what the up-and-coming cannabinoid is, where it comes from, and its legal status. The cannabinoid Delta-8-THC is a natural component of cannabis, Russo says. “[W]ith Where It Comes From. That is totally wrong.”.

DEA 52

DEA Cannabinoids Research and Development THC 52

Veriheal

DECEMBER 1, 2020

Cannabinoid science is an area that is rapidly advancing across the United States. THC is the prominent intoxicating cannabinoid in cannabis that we know of. When it comes to scientific research and the way of Delta-8-THC, it is scarce. The DEA is Already Interfering. The abbreviation stands for tetrahydrocannabinol.

THC 52

THC DEA Research and Development Cannabinoids 52

MedicalJane

JUNE 29, 2018

Food and Drug Administration (FDA) had approved only three cannabinoid-based medicines. On June 26, 2018, the FDA granted approval of Epidiolex, a cannabidiol (CBD) oral solution, to GW Research Ltd (GW). percent of tetrahydrocannabinol (THC), the cannabinoid responsible for producing “high” psychoactive effects when consumed.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Cannabis Law Report

JUNE 4, 2021

Dr. Titus has been involved in the development and investment of several industry-leading cannabis and industrial hemp businesses during his most recent career. Dr. Titus developed several prominent cannabis companies, including HempMeds, KannaLife Sciences Inc, and Kannaway, LLC.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Cannabis Law Report

JULY 28, 2021

To a large extent legalization of adult-use cannabis, including New York’s passage of the Marijuana Regulation and Taxation Act of 2021 (MRTA), has eclipsed other developments in the cannabis sector over the past year. 5940), which allows hemp to be cultivated for research (as opposed to commercial) purposes. ” See 7 U.S.C.

THC 105

THC Hemp CBD Cannabinoids 105

Cannabis Law Report

JULY 28, 2022

Testimonies During The House Agriculture Subcommittee On Biotechnology, Horticulture, And Research Addressed FDA Inaction on CBD and Intoxicating Hemp Derivatives. Food and Drug Administration (FDA) to regulate hemp derived cannabinoids such as CBD continues to negatively impact the industry. Washington D.C. Today, U.S.

Agriculture 52

Agriculture Hemp CBD Research and Development 52

Cannabis Law Report

AUGUST 12, 2022

Mainstreaming Cannabinoids – Path To Legalization. Obtaining DEA License to Grow Psilocybin Mushrooms. This panel would explore topics such as the ethical implications of psychedelic-based drug development and patenting, as well as the debate over producing and marketing natural versus synthetic psychedelics.

Research and Development 52

Research and Development Events Topical Policy 52

United Patients Group

APRIL 3, 2023

Epidiolex, an FDA-approved medication containing CBD (cannabidiol), has been listed as Schedule 5 by the DEA since June 25th, 2019. Another for of ‘prescribed’ cannabis is Marinol , which is synthetic THC, developed in the 80’s and used for such conditions as Cancer and AIDS. Cannabis is a schedule 1 substance.

DEA 52

DEA Patients Conditions Cannabis 52

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

Weedistry

MARCH 7, 2019

Mounting evidence shows cannabinoids in marijuana slow cancer growth, inhibit formation of new blood cells that feed a tumor, and help manage pain, fatigue, nausea, and other side effects. Marijuana Fights Cancer and Helps Manage Side Effects, Researchers Find.

THC 40

THC CBD Clinical Trials Research and Development 40

The Joint Blog

JUNE 4, 2021

Believe it or not, you actually need a license to do meaningful research on marijuana due to the fact that the United States Drug Enforcement Agency (DEA) has limited its access. The DEA feels that marijuana, being a schedule I drug, could be misused like other drugs within that category and could be dangerous. Appetite loss.

Conditions 32

Conditions Chronic Pain Marijuana Research and Development 32

The Cannigma

JULY 3, 2023

The clues we have from existing literature indicate that while it’s probably safe, there’s insufficient clinical research to confirm or dispel it. Happily, the body of research into cannabis and psychedelics (including MDMA) is expanding fast, and it’s likely that better data on their interactions will become available in the near future.

Research and Development 46

Research and Development Environment THC Microdosing 46

Cannabis Law Report

APRIL 1, 2019

The Tobacco Authority of Thailand, or TOAT, is one of two governmental entities that has looked to capitalize on the sale of cannabinoids as soon as it received approval from the Food and Drug Administration, or FDA. It remains to be seen whether the Drug Enforcement Authority, or DEA, will designate cannabis zones for these farmers.

Research and Development 40

Research and Development Pharmaceutical Clinical Trials DEA 40

Canna Law Blog

APRIL 22, 2020

the current and future treatment of emerging cannabinoids beyond CBD such as CBG , CBN , and synthetic CBD. researchers and companies to do so. legalized hemp in 2018, leading to a hemp-derived cannabinoid marketplace that is rapidly eclipsing the legal adult-use marijuana market. Some understand some of the nuances of the U.S.,

Supply Chain 54

Supply Chain Research and Development Hemp DEA 54

Cannabis Law Report

SEPTEMBER 20, 2019

DEA increases the cannabis research quota. The Drug Enforcement Administration (DEA) announced annual quotas for the manufacture of controlled substances for research purposes, providing for 7,000 pounds of cannabis to be used in scientific studies. This represents a 30 percent increase from the 2019 cannabis quota.

Vaping 40

Vaping Banking Research and Development DEA 40

Cannabis Law Report

NOVEMBER 2, 2021

This is a well researched and detailed report and is, we suggest required reading. Delta-8 THC is making big waves in the cannabis industry at the minute, but with warnings from the FDA and CDC , not to mention harrowing accounts from users , it’s clear there’s more going on with the novel cannabinoid than meets the eye.

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). Barriers to facilitating both clinical and public health research regarding marijuana is detrimental to treating patients and the health of the public. Executive Summary. The World Health Organization (WHO) reports approximately 2.5%

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Project CBD

AUGUST 23, 2023

Earlier this year, the Food & Drug Administration disclosed that it would not regulate non-pharmaceutical CBD products, thereby putting the onus on Congress to devise an appropriate regulatory framework for cannabidiol and other hemp-derived cannabinoids. percent on a dry weight basis.”

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

Cannabis Law Report

JANUARY 11, 2019

Furthermore, by redefining hemp to include its “extracts, cannabinoids and derivatives,” Congress explicitly removed popular hemp products – such as hemp-derived CBD — from the purview of the CSA. While the DEA is now officially out of the hemp regulation business, the U.S.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

Veriheal

JUNE 29, 2021

Did we ever stop to think that if we could legally utilize the plants in the first place that perhaps we wouldn’t develop terminal illnesses at such a high rate? The lawsuit came after the DEA denied their application to utilize a synthetic form of psilocybin under the RTT laws. Cannabinoid Therapies for Cancer Patients.

Therapy 55

Therapy DEA Patients Clinical Trials 55

Cannabis Law Report

NOVEMBER 17, 2022

This collaboration ensures first-of-their-kind consistent cannabinoid compositions for 575 DEA-licensed cannabis medical research institutions developing cures for PTSD, pain management, anxiety conditions and more Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp.

Research and Development 52

Research and Development Pharmaceutical DEA Cannabinoids 52

Cannabis Info

OCTOBER 4, 2019

The Scientist Who Identified THC Is Now Working on Synthetic Cannabinoids. Dr. Raphael Mechoulam , the scientist who first recognized the THC molecule in 1965, introduced his latest mission in California final week: constructing artificial cannabinoids. The plant produces a group of compounds called cannabinoid acids.

Cannabinoids 45

Cannabinoids THC Wellness and Beauty Research and Development 45

Veriheal

MAY 4, 2022

Well, according to a team of researchers from the United States and Switzerland, the cardiovascular outcome of using the plant is actually quite positive. The Coronary Artery Risk Development in Young Adults (CARDIA),” the study was published in the American Journal of Medicine. But just how true are these claims?

Research and Development 98

Research and Development Consumption Vaping Edibles 98

Cannabis Law Report

JUNE 1, 2021

Operating expenses : Total SG&A (“SG&A”) expenses in Q4 2021 declined by 25% versus Q4 2020, driven by year-over-year reductions in Sales & Marketing, and Research and Development (“R&D”) expenses. Drug Enforcement Administration (the “DEA”), the U.S. hemp industry in the U.S.,

Data 95

Data Vaping Supply Chain Business 95

The Cannigma

SEPTEMBER 12, 2021

There are a lot of different molecules in nature, and though cannabinoids are rather rare, they are extremely abundant in cannabis (hence the name). THC is the most prevalent, famous and researched cannabinoid by far. The first researcher who identified and isolated THC, was the American Roger Adams (Shutterstock).

THC 98

THC Research and Development Cannabinoids CBD 98